These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1760938

  • 1. Evaluation of BRL 42715, a beta-lactamase-inhibiting penem.
    Qadri SM, Ueno Y, Burdette M, Kroschinsky R, Almodovar E.
    Chemotherapy; 1991; 37(6):398-404. PubMed ID: 1760938
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM, Ueno Y, Cunha BA.
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [Abstract] [Full Text] [Related]

  • 3. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
    Coleman K, Griffin DR, Page JW, Upshon PA.
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1580-7. PubMed ID: 2817854
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC, Chin NX, Neu NM.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [Abstract] [Full Text] [Related]

  • 5. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Shannon K, King A, Phillips I.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA, Hare R, Papa E, Adam C, Miller GH.
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
    Minamimura M, Taniyama Y, Inoue E, Mitsuhashi S.
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1547-51. PubMed ID: 8363389
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of HRE 664, a penem antibiotic.
    Chin XN, Neu HC.
    Diagn Microbiol Infect Dis; 1990 Jul; 13(6):509-16. PubMed ID: 2279381
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patients.
    Rolston KV, Alvarez ME, Hoy JF, Alderman HC, Ho DH, Bodey GP.
    Chemotherapy; 1986 Jul; 32(6):506-14. PubMed ID: 3100147
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.
    Testa R, Cantón R, Giani T, Morosini MI, Nichols WW, Seifert H, Stefanik D, Rossolini GM, Nordmann P.
    Int J Antimicrob Agents; 2015 Jun; 45(6):641-6. PubMed ID: 25748553
    [Abstract] [Full Text] [Related]

  • 14. Comparative antimicrobial activities of the penem WY-49605 (SUN5555) against recent clinical isolates from five U.S. medical centers.
    Sewell D, Barry A, Allen S, Fuchs P, McLaughlin J, Pfaller M.
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1591-5. PubMed ID: 7492110
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM.
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [Abstract] [Full Text] [Related]

  • 16. [Antibacterial activity of sulopenem, a new parenteral penem antibiotic].
    Inoue E, Komoto E, Taniyama Y, Mitsuhashi S.
    Jpn J Antibiot; 1996 Apr; 49(4):338-51. PubMed ID: 8786625
    [Abstract] [Full Text] [Related]

  • 17. In-vitro activity of a new penem FCE 22101.
    Hoban DJ.
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():53-7. PubMed ID: 2786518
    [Abstract] [Full Text] [Related]

  • 18. Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.
    Appelbaum PC, Spangler SK, Shiman R, Jacobs MR.
    Antimicrob Agents Chemother; 1992 May; 36(5):1140-3. PubMed ID: 1324639
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of ertapenem: review of recent studies.
    Wexler HM.
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [Abstract] [Full Text] [Related]

  • 20. Comparative in vitro activity of CGP 31608, a new penem antibiotic.
    Eliopoulos GM, Wennersten C, Reiszner E, Moellering RC.
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1188-93. PubMed ID: 3498437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.